14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 70 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HBP.TO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Helix BioPharma Corp. stock price down 0% on Friday
(Updated on May 17, 2024)

Buy or Hold candidate since Apr 24, 2024 Gain 7.69% PDF

No changes to the price of Helix BioPharma Corp. stock on the last trading day (Friday, 17th May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.210 to a day high of $0.210. The price has been going up and down for this period, and there has been a 2.44% gain for the last 2 weeks.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.27% during the next 3 months and, with a 90% probability hold a price between $0.233 and $0.289 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HBP.TO Signals & Forecast

The Helix BioPharma Corp. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.219. On a fall, the stock will find some support from the long-term average at approximately $0.200. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, May 14, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Monday, April 08, 2024 with a target of $0.183. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Helix BioPharma Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.190 and $0.185. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Helix BioPharma Corp. finds support just below today's level at $0.190. If this is broken, then the next support from accumulated volume will be at $0.185 and $0.180.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 2.38%

Our recommended stop-loss: $0.197 (-6.16%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (HBP.TO) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Helix BioPharma Corp. to open at $0.210, and during the day (based on 14 day Average True Range), to move between $0.203 and $0.217, which gives a possible trading interval of +/-$0.0073 (+/-3.47%) up or down from last closing price. If Helix BioPharma Corp. takes out the full calculated possible swing range there will be an estimated 6.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.220 (4.76%) than the support at $0.190 (9.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Helix BioPharma Corp. stock A Buy?

Helix BioPharma Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Helix BioPharma Corp. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
$0.210 ( 0%) $0.210

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HBP.TO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.210 .
R2 0.210 .
R1 0.210 .
Current price: 0.210
Support S1 0.210 .
S2 0.210 .
S3 0.210 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0.230 9.52 %
R1 0.220 4.76 %
Current price 0.210
Support S1 0.190 -9.52%
S2 0.185 -11.90%
S3 0.180 -14.29%

FAQ

What is the symbol for Helix BioPharma Corp. Stock and on which exchange is it traded?
The symbol for Helix BioPharma Corp. is HBP.TO and it is traded on the TSX (Toronto Stock Exchange).

Should I buy or sell Helix BioPharma Corp. Stock?
Helix BioPharma Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Helix BioPharma Corp. Stock?
Helix BioPharma Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Helix BioPharma Corp. Stock.

What's the current price of Helix BioPharma Corp. Stock?
As of the end of day on the May 17, 2024, the price of an Helix BioPharma Corp. (HBP.TO) share was $0.210.

What is the 52-week high and low for Helix BioPharma Corp. Stock?
The 52-week high for Helix BioPharma Corp. Stock is $0.260 and the 52-week low is $0.150.

What is the market capitalization of Helix BioPharma Corp. Stock?
As of the May 17, 2024, the market capitalization of Helix BioPharma Corp. is 45.502M.

When is the next earnings date for Helix BioPharma Corp.?
The upcoming earnings date for Helix BioPharma Corp. is Jun 12, 2024.
Click to get the best stock tips daily for free!

About Helix BioPharma Corp.

Helix BioPharma . Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biote... HBP.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT